Articles published by Neoleukin Therapeutics, Inc.
![](https://ml.globenewswire.com/media/9cc435b8-990a-4937-9060-0bfb160a5353/small/neoleukin-png.png)
Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
December 14, 2023
Via GlobeNewswire
Tickers
NLTX
![](https://ml.globenewswire.com/media/9cc435b8-990a-4937-9060-0bfb160a5353/small/neoleukin-png.png)
Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
September 22, 2023
Via GlobeNewswire
Tickers
NLTX
![](https://ml.globenewswire.com/media/9cc435b8-990a-4937-9060-0bfb160a5353/small/neoleukin-png.png)
Via GlobeNewswire
Tickers
NLTX
![](https://ml.globenewswire.com/media/9cc435b8-990a-4937-9060-0bfb160a5353/small/neoleukin-png.png)
![](https://ml.globenewswire.com/media/9cc435b8-990a-4937-9060-0bfb160a5353/small/neoleukin-png.png)
![](https://ml.globenewswire.com/media/9cc435b8-990a-4937-9060-0bfb160a5353/small/neoleukin-png.png)
Neoleukin Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Update
November 14, 2022
Via GlobeNewswire
Tickers
NLTX
![](https://ml.globenewswire.com/media/9cc435b8-990a-4937-9060-0bfb160a5353/small/neoleukin-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.